Biospecifics Technologies (BSTC) Reports Q2 EPS of $0.24

August 10, 2015 5:25 PM EDT

Biospecifics Technologies (NASDAQ: BSTC) reported Q2 EPS of $0.24, versus $0.08 reported last year. Revenue for the quarter came in at $4.7 million versus the consensus estimate of $2.6 million.

For earnings history and earnings-related data on Biospecifics Technologies (BSTC) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings